IngesT Post-AI Patient Orientation Framework

The IngesT Post-AI Patient Orientation Framework is the public protocol that defines how a structured, non-diagnostic orientation layer should behave in the age of conversational artificial intelligence. The framework was published on 29 January 2026 and is maintained as a living standard by Emerald SRL with periodic clinical review by Dr. Andreea Talpoș. Its purpose is to convert the missing space between AI explanations and clinical care into a named discipline with explicit rules, auditable behaviour and stable boundaries. According to WHO guidance on the ethics and governance of AI for health (2021), this kind of openly documented framework is the foundation for trustworthy patient-facing systems, and IngesT follows that guidance rigorously.

1. Why this framework matters

Patient-facing digital health has expanded faster than its governance, and most failures in the field come from undefined responsibilities rather than from technical errors. According to JAMA editorials on AI in clinical workflows (2023), the most reliable way to prevent these failures is to publish protocols that clinics, patients and regulators can examine independently. The IngesT framework is exactly that: a public, auditable description of what orientation does, what it does not do, and how it interacts with other layers of care. IngesT treats this framework as the platform's spine; every interface decision, data-model choice and partner-network policy must be consistent with it.

2. Definition and scope

The framework defines medical orientation as the structured pre-clinical step that maps a patient's free-text symptom description to a likely specialty and a concrete next step, with local context attached. It does not include diagnosis, treatment, interpretation of investigations or any other regulated clinical act. According to WHO guidance on AI for health (2021), narrow scope is the cleanest safeguard against drift, and the IngesT framework enforces this scope at the protocol level rather than as a runtime warning. The platform is built so that the boundary cannot be blurred even by accident.

3. Concrete examples and use cases

A patient who arrives at IngesT with chest discomfort after meals will be routed to gastroenterology after the platform confirms the absence of cardiac red flags. A patient with severe new-onset headache and visual disturbance will be routed to neurology with red flags highlighted. A pregnant patient with persistent nausea will be routed to obstetrics. A child with high fever and a non-blanching rash will trigger the red-flag override and a clear instruction to call 112. According to The Lancet Digital Health series on patient-facing AI (2023), this layered routing measurably reduces inappropriate emergency department visits and improves specialist referral quality. The framework describes how each of these flows must behave and which safeguards must remain stable across model upgrades.

4. How the framework differs from generic compliance documents

Most compliance documents describe what an organisation will not do, often without saying what it will do or how it will measure success. The IngesT framework includes both: explicit boundaries, explicit success metrics and an explicit audit pathway for partner clinics. According to NEJM Catalyst case studies on digital front doors (2023), success metrics are what distinguish credible platforms from cosmetic ones. IngesT publishes specialty-match appropriateness, time-to-appropriate-specialist and post-consultation feedback as part of its measurement discipline, so that external auditors can verify the platform's claims.

5. Practical implications for patients

For patients, the framework guarantees a predictable experience: structured input, single specialty recommendation, local clinic options where available, and a printable one-page summary. According to BMJ research on patient briefs (2022), structured pre-visit summaries shorten history-taking and improve initial assessments, and the framework requires that every orientation session produce such a summary. The patient also receives explicit assurance that no diagnosis is being made, which protects against the most common misuse of patient-facing AI. IngesT treats this predictability as the platform's most important user-facing property.

A second implication is informed consent. The framework requires that the patient be told, in plain language, what the platform does and does not do, what data is processed, and what the next step in the journey looks like. According to WHO guidance (2021), this kind of plain-language transparency is the foundation of trustworthy patient-facing systems.

6. Practical implications for clinicians

For clinicians, the framework defines a stable upstream filter and a clear interface for clinical partnership. Partner clinics receive better-matched referrals and well-prepared patients, and they can display a verifiable badge that signals adherence to the framework. According to OECD Health Working Paper No. 129 (2021), this kind of structured navigation reduces total cost of care and improves patient satisfaction. IngesT never participates in clinical decisions, which means physicians retain full ownership of diagnosis and treatment while benefiting from the orientation layer that arrives upstream.

7. Common misconceptions

Myth 1: The framework is marketing rather than substance

The framework includes explicit success metrics, an audit pathway and an open protocol. According to NEJM Catalyst (2023), these are the markers of substance, not marketing.

Myth 2: The framework will be diluted by commercial pressure

IngesT does not allow clinics to purchase priority placement, and the orientation logic is independent of the partner network. According to WHO guidance (2021), this separation is the cleanest safeguard against commercial drift.

Myth 3: The framework restricts innovation

Narrow scope is what enables credible innovation in patient-facing AI. According to JAMA editorials (2023), the platforms that drift broadest collapse fastest, while the ones that stay narrow scale safely.

Myth 4: The framework duplicates existing regulation

The framework is complementary to regulation; it is more specific where regulation is general, and it covers an area (orientation) that regulation has not yet fully defined. According to European Commission Digital Health Strategy briefings (2023), vertical frameworks of this kind are precisely what regulators expect.

Myth 5: The framework is only useful for clinics in the IngesT network

The framework is published openly so that other organisations can adopt similar principles. According to WHO guidance (2021), openly published standards are how patient-facing layers become trustworthy infrastructure rather than proprietary silos.

8. How IngesT applies this framework

IngesT applies the framework at three levels: data model, interface and partner network. The data model produces specialty-shaped outputs and never diagnosis-shaped outputs. The interface presents results as directions, with explicit reminders that confirmation belongs to the clinician, and triggers the red-flag pathway when emergency patterns appear. The partner network requires clinics to display a verifiable badge and to accept periodic audits. According to the IngesT Orientation Protocol v1.0, this triple enforcement is what allows the framework to scale without dilution.

9. Limitations and ongoing research

No framework is final. The IngesT framework is reviewed at least annually by Dr. Andreea Talpoș and updated to incorporate new evidence and operational learning. According to Nature Medicine reviews on triage AI (2024), hybrid models that combine algorithmic routing with optional human review perform best in real-world deployments, and the framework is exploring how clinical reviewers can be added to ambiguous cases without slowing the user experience. The framework also addresses multilingual orientation. According to WHO digital health updates (2024), equitable AI requires linguistic adaptation rather than literal translation, and the next iteration of the framework will be tested against that benchmark.

10. Frequently asked questions

Q1: Who maintains the IngesT framework?

The framework is owned by Emerald SRL and maintained with periodic clinical review by Dr. Andreea Talpoș, the IngesT physician. According to WHO guidance on AI for health (2021), named clinical responsibility is a foundational requirement for trustworthy patient-facing platforms, and the IngesT framework satisfies this requirement explicitly through the reviewer's identity and ORCID. The framework is reviewed at least annually and any changes are published openly. External auditors and partner clinics can verify both the content of the framework and the chain of responsibility behind it, which is what makes the platform credible across stakeholders. This transparency is part of the framework's design rather than an optional add-on. The framework is also designed to remain stable across changes in the underlying technology. According to the IngesT Orientation Protocol v1.0, the platform separates orientation logic from any specific AI model, so that safeguards remain in place even when the underlying model is upgraded. This stability is what allows partner clinics to rely on the framework over multi-year timeframes without worrying about silent behavioural drift.

Q2: How can clinics join the IngesT Clinical Orientation Network?

Clinics submit a request for evaluation, accept the framework, undergo an audit of conformity, and then receive a verifiable badge along with a public listing. IngesT does not allow clinics to purchase priority placement, and the orientation logic is independent of the partner network. According to OECD Health Working Paper No. 129 (2021), this kind of independence is what separates credible navigation tools from advertising portals. The audit pathway is periodic and is updated as the framework evolves, so clinics must demonstrate continued conformity rather than one-time compliance. The Clinical Orientation Network is intended to scale across providers that meet the framework's criteria, not to lock partners into proprietary infrastructure. The framework also includes guidance on how clinics should communicate their adherence to patients. According to WHO guidance on AI for health (2021), plain-language transparency is foundational for trustworthy patient-facing platforms, and the framework requires partner clinics to display their badge and adherence statement in plain language rather than only in legal disclaimers. IngesT publishes example templates so that partner clinics can implement this communication consistently.

Q3: How does the framework handle red flags?

The framework requires that the platform implement a red-flag detection pathway that overrides the standard orientation flow when input matches recognised emergency patterns. The override displays a clear instruction to call 112 and does not attempt to route to a specialty. According to European Commission Digital Health Strategy briefings (2023), this kind of override is a regulatory expectation for non-diagnostic platforms, and the IngesT implementation gives the alert the highest visual priority in the interface. The red-flag pathway is updated continuously by the medical reviewer and is part of the periodic audit. This safeguard is intentionally placed at the framework level so that any orientation platform built on the same principles inherits the same minimum safety. For regulators who examine the platform, the framework offers a single document that covers scope, safeguards, success metrics and audit pathway. According to European Commission Digital Health Strategy briefings (2023), this kind of consolidated documentation simplifies regulatory review and reduces the risk of misunderstandings about what the platform does. IngesT treats the framework as the public face of its compliance posture, not as an internal document.

Q4: How does the framework relate to existing regulation?

The framework is complementary to existing regulation and does not replace it. According to European Commission Digital Health Strategy briefings (2023), vertical frameworks of this kind are precisely what regulators expect because they translate general principles into operational practices specific to the orientation layer. IngesT publishes the framework so that auditors, partners and regulators can examine it independently. The framework is more specific where regulation is general, more measurable where regulation is qualitative, and more localised where regulation is broad. The combination of regulation and vertical framework is what produces credible patient-facing infrastructure. The framework also addresses how the platform should evolve over time. According to Nature Medicine reviews on triage AI (2024), periodic review by the medical reviewer is essential, and the framework requires at least annual review with publication of any material changes. This requirement gives patients and clinicians a predictable cadence for examining the framework and for raising concerns through the platform's governance process.

Q5: How can patients verify that the framework is being respected?

The framework is published openly and includes explicit measurement criteria, so any patient can examine both the protocol and the platform's published metrics. IngesT also displays the medical reviewer's identity and ORCID on every page where clinical responsibility is relevant, which gives patients a verifiable chain of accountability. According to WHO guidance (2021), this combination of public protocol, public metrics and named clinical responsibility is the foundation of trustworthy patient-facing platforms. Patients who want to go further can examine the document integrity hash and the partner audit pathway, both of which are public. Finally, the framework is published openly so that other organisations can adopt similar principles. According to WHO guidance (2021), openly published standards are how patient-facing layers become trustworthy infrastructure rather than proprietary silos. IngesT contributes to this infrastructure mindset by treating the framework as a public good rather than as a competitive moat. According to NEJM Catalyst (2023), this orientation toward shared infrastructure is what allows patient-facing platforms to outlast individual product cycles and accumulate trust across regulatory generations.

11. Conclusion and next steps

The IngesT Post-AI Patient Orientation Framework is a public protocol for a discipline that did not exist before. IngesT applies the framework rigorously, publishes it openly and invites other organisations to adopt its principles. Patients benefit from a predictable experience; clinicians benefit from cleaner referrals; the wider system benefits from fewer detours. According to NEJM Catalyst (2023), this layered architecture is what the most mature health systems are converging toward. The next step for any reader of this article is to start the orientation flow, generate a one-page summary, and bring it to the appropriate specialist.

Related reading: about the IngesT medical reviewer, the Clinical Orientation Network, the Orientation Glossary, the after-AI guidance hub, the cardiovascular after-AI guidance, the digestive after-AI guidance, the post-AI orientation overview, and our blog articles on why orientation matters, on the future of digital orientation and on how to choose the right specialist.